{"ParsedSentences":["(ROOT (S (NP (QP (CD 768729128) (CD |)) (NNP TMC) (NNP |) (CD 84870302) (NNP |) (NNP |) (CD 4841712) (JJ |) (QP (CD 6/4/2005) (CD 12:00:00)) (JJ AM) (NNS |)) (VP (VBP GRAFT) (SBAR (S (NP (NP (NNP VS) (NNP HOST) (NNP DISEASE)) (, ,) (NP (NP (NP (NNP S/P) (NNP BONE) (NNP MARROW) (NNP TRANSPLANT) (NNP |)) (NP (NNP Signed) (NNP |) (NNP DIS) (NNP |) (NNP Admission) (NNP Date))) (: :) (NP (NP (CD 4/1/2005)) (NP (NNP Report) (NNP Status))) (: :) (NP (NP (NNP SignedDischarge) (NNP Date)) (: :) (NP (CD 10/15/2005ATTENDING))) (: :) (NP (NP (NNP BABILONIA)) (, ,) (NP (NNP HARRISON) (NNP LENARD) (NNP HILARIOPRINCIPAL) (NNP DIAGNOSIS))) (: :) (NP (NP (NNP Graft)) (PP (IN versus) (NP (NP (NN host) (NN disease.HISTORY)) (PP (IN OF) (NP (NNP PRESENT) (NNP ILLNESS)))))) (: :) (NP (NP (DT The) (NN patient)) (PP (IN in) (NP (NP (CD 1/25)) (ADJP (JJ developed) (JJ right)) (NN breast) (NN cancer))))) (, ,)) (VP (VBP stage) (SBAR (S (NP (NNP III.Treatment)) (VP (VBD included) (ADJP (JJ lumpectomy) (CC and) (JJ chemotherapy))))))))) (. .)))","(ROOT (S (NP (DT The) (NN patient)) (VP (VBP hadpersistent) (NP (NP (NN pancytopenia)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN evaluated) (PP (IN in) (NP (CD 10/4))) (PP (IN with) (NP (NP (NN bonemarrow) (NN aspirate) (NN biopsy)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD showed) (NP (JJ multiple) (NNS cytogeneticabnormalities)) (PP (IN with) (NP (NP (NNS findings)) (ADJP (JJ consistent) (PP (IN with) (NP (NN myelodysplasticsyndrome))))))))))))))))) (. .)))","(ROOT (S (PP (IN In) (NP (CD 8/14))) (, ,) (NP (PRP she)) (VP (VBD had) (NP (NP (DT a) (JJ nonmyeloblative) (JJ peripheral) (NN bloodstem) (NN cell) (NN transplant)) (PP (IN for) (NP (DT a) (NN match) (JJ unrelated) (NN donor))))) (. .)))","(ROOT (S (PP (IN In) (NP (CD 10/18))) (, ,) (NP (NN shehad)) (VP (VBP lymphocyte) (NP (NN infusion))) (. .)))","(ROOT (S (PP (IN On) (NP (CD 5/8))) (, ,) (NP (NN chimerism) (NN study)) (VP (VBD showed) (NP (ADJP (CD 58) (NN %)) (NN donor) (NN origin))) (. .)))","(ROOT (S (NP (NP (NN Repeat) (NN chimerism)) (PP (IN on) (NP (CD 8/23/05)))) (VP (VBD showed) (NP (ADJP (CD 100) (NN %)) (NN chimerism))) (. .)))","(ROOT (S (NP (DT The) (ADJP (JJ patient) (PP (RB prior) (TO to) (NP (NP (NN admission)) (PP (IN for) (NP (CD two) (NNS weeks)))))) (NN haddiarrhea)) (, ,) (VP (VBZ watery) (PP (IN in) (NP (NN nature)))) (. .)))","(ROOT (SINV (S (NP (PRP She)) (VP (VBD denied) (NP (JJ sick) (NNS contacts)))) (, ,) (VP (VBD had) (NP (NP (NNP GIbiopsy)) (PP (IN in) (NP (NP (NN middle)) (PP (IN of) (NP (CD 5/24))))) (SBAR (WHNP (WDT that)) (S (VP (VBD showed)))))) (NP (NP (JJ focal) (NNS colitis)) (, ,) (NP (NP (NNS withoutsigns)) (PP (IN of) (NP (NNP GVHD))))) (. .)))","(ROOT (S (NP (DT The) (NN patient)) (VP (VP (VBD was) (VP (VBN given) (NP (NP (NN prescription)) (PP (IN for) (NP (JJ steroidsthree) (NNS days)))) (ADVP (RB prior) (PP (TO to) (NP (NN admission)))))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (VB complete) (CC or) (VB fill) (NP (NN theprescription)))) (, ,) (VP (VBD was) (VP (VBN admitted) (PP (IN from) (NP (DT the) (NN clinic))) (PP (IN with) (NP (NP (JJ significant) (NN skinrash)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (ADJP (JJ consistent) (PP (IN with) (NP (NP (NN graft)) (PP (IN versus) (NP (NN host) (NN disease.PAST) (NNP MEDICAL) (NNP HISTORY))))))))))))) (: :) (VP (VBZ Includes) (NP (NN breast) (NN cancer)) (PP (IN in) (NP (NP (CD 1/25)) (, ,) (NP (JJ myelodysplastic) (NN syndrome)) (, ,) (NP (NN hypertension)) (, ,) (CC and) (NP (NN hypercholesterolemia)))))) (. .)))","(ROOT (S (S (NP (DT The) (NN patient)) (VP (VP (VBD had) (VP (VBN isolatedcomplicated) (NP (JJ migraine) (NN headache)))) (CC and) (VP (VBZ has) (NP (JJ aortic) (NN valvular) (NN diseasewith) (NN aortic) (NNS insufficiency.ALLERGIES))))) (: :) (S (NP (PRP She)) (VP (VBZ describes) (S (NP (DT no) (NNS allergies)) (VP (TO to) (VP (VB medications.SOCIAL) (NP (NNP HISTORY))))))) (: :) (S (NP (PRP She)) (VP (VBZ is) (VP (VBN divorced) (PP (IN with) (NP (NP (CD one) (NN son)) (, ,) (NP (JJ denies) (NN alcohol)) (CC or) (NP (JJ illicit) (NN drugintake.FAMILY) (NN HISTORY))))))) (: :) (S (NP (NNP Noncontributory.PHYSICAL) (NNP FINDINGS)) (: :) (PP (IN On) (NP (NN exam))) (NP (JJ vital) (NNS signs)) (VP (VBD were) (ADJP (JJ stable)))) (. .)))","(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (NN drymaculopapular) (NN rash)) (PP (IN over) (NP (NP (DT the) (JJ upper) (NN chest) (CC and) (NN face)) (, ,) (ADVP (RB also)) (NP (JJ includingthe) (JJ upper) (NNS extremities)) (, ,) (NP (NN abdomen)) (, ,) (CC and) (NP (JJ upper) (NNS thighs)))) (ADJP (JJ bilaterally) (, ,) (JJ flat) (, ,) (RB slightly) (JJ erythematous)))) (. .)))","(ROOT (S (NP (NNP HEENT) (NNP exam)) (VP (VBD was) (ADJP (JJ normal))) (. .)))","(ROOT (S (NP (PRP She)) (VP (VBD had) (NP (JJ drymucous) (NNS membranes))) (. .)))","(ROOT (S (S (NP (NNP Chest)) (VP (VBZ is) (ADJP (JJ clear) (PP (TO to) (NP (NP (NN percussion)) (CC and) (NP (JJ auscultation.Cardiac) (NN exam))))))) (: :) (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT a) (ADJP (NP (CD 2/6)) (JJ systolic)) (NN ejection) (NN murmur) (NN heardbest)) (PP (IN in) (NP (DT the) (JJ aortic) (NN area)))))) (. .)))","(ROOT (S (NP (NNP Abdomen)) (VP (VBZ is) (ADJP (JJ soft) (CC and) (JJ nontender))) (. .)))","(ROOT (S (ADVP (RB Thereis)) (NP (DT no) (NN hepatosplenomegaly)) (VP (VBD appreciated) (PP (IN on) (NP (JJ clinical) (NN exam)))) (. .)))","(ROOT (S (NP (PRP She)) (VP (VBP haslarge) (NP (JJ external) (NNS hemorrhoids))) (. .)))","(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (NN clubbing)) (, ,) (NP (NP (NNS cyanosis)) (, ,) (NP (NN oredema))))) (. .)))","(ROOT (S (NP (JJ Neurological) (NN exam)) (VP (VBZ is) (ADJP (JJ nonfocal.HOSPITAL) (NP (NNP COURSE) (CD :1)))) (. .)))","(ROOT (S (ADVP (RB Oncology)) (: :) (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (NNP MDS)) (, ,) (NP (ADJP (NP (CD 11) (NNS months)) (JJ statuspost)) (JJ nonmyeloablative) (NN transplant)))))) (. .)))","(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (ADJP (RB very) (JJ slow)) (NP-TMP (NP (NN toengraft)) (CC and) (NP (VBN required) (NN donor) (NN lymphocyte) (NN infusion)))) (. .)))","(ROOT (S (NP (NP (JJS Most) (NN recentchimerism) (NNS studies)) (PP (IN on) (NP (CD 8/23/05)))) (VP (VBD showed) (NP (DT a) (ADJP (CD 100) (NN %)) (NN donor) (NN origin))) (. .)))","(ROOT (S (NP (NNP Thepatient)) (VP (VBD had) (VP (NN stage) (NP (NP (NNP III) (NN skin) (NNP GVH)) (VP (VBN confirmed) (PP (IN by) (NP (NP (NN biopsy)) (PP (IN on) (NP (CD 6/15/05))))))))) (. .)))","(ROOT (S (NP (PRP She)) (VP (VBD had) (NP (NP (JJ moderate) (NN improvement) (NN response)) (PP (TO to) (NP (NP (NNP Solu-Medrol)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBN wasstarted) (PP (IN on) (NP (NP (CD 8/5/05)) (PRN (-LRB- -LRB-) (VP (VBN switched) (S (VP (TO to) (VP (VB prednisone) (PP (IN on) (NP (CD 6/11/05))))))) (-RRB- -RRB-)) (NP (NP (NN andElidel)) (VP (VBN started) (PP (IN on) (NP (CD 5/22/05)))))))))))))) (. .)))","(ROOT (S (NP (EX There)) (VP (VBZ has) (VP (VBN been) (ADVP (RB even) (RBR more)) (VP (VBN improvementin) (NP (DT the) (NN skin) (NN GVH)) (PP (IN since) (S (VP (VBG initiating) (NP (NN rapamycin)) (PP (IN on) (NP (JJ 8/6Gut) (NNP GVH/diarrhea))))))))) (. .)))","(ROOT (SINV (S (NP (NP (NNP GI)) (VP (ADVP (RB biopsy)) (VBN done) (PP (IN on) (NP (CD 5/10/05))))) (VP (VBD showed) (NP (NN grade)) (NP (NP (NNP IIgraft)) (PP (IN versus) (NP (NN host) (NN disease)))) (PP (IN in) (NP (JJ left) (NN transverse) (NN colon))) (, ,) (NP (NP (NN grade)) (SBAR (S (NP (PRP I)) (VP (VBZ graftversus) (NP (NP (NN host) (NN disease)) (PP (IN in) (NP (NN rectum)))) (, ,) (PP (IN with) (NP (DT no) (JJ viral) (JJ cytopathic) (NN changes.The) (NN patient))))))))) (VP (VBD had) (NP (NP (DT no) (JJ significant) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN stoolswith))))))) (NP (NP (NNP Solu-Medrol)) (, ,) (NP (NP (JJ marginal) (NN response)) (PP (TO to) (NP (NP (NN rapamycin)) (, ,) (ADVP (RB now) (PP (IN with) (NP (JJ someimprovement) (NN status) (NN post)))) (NP (NP (CD three) (NNS doses)) (PP (IN of) (NP (NNP ONTAK)))))))) (. .)))","(ROOT (S (NP (NNP ONTAK)) (VP (VBD was) (VP (VBN given) (NP (NP (CD on6/17/05) (, ,) (CD 9/6/05) (, ,) (CC and) (CD 10/22/05)) (PP (IN without) (NP (JJ adverse) (NNS events)))))) (. .)))","(ROOT (S (NP (NNP Thepatient)) (VP (VBD was) (VP (VBN premedicated) (PP (IN with) (NP (NNP Pepcid) (, ,) (NNP steroids) (, ,) (NNP Benadryl) (, ,))) (ADVP (RB andTylenol)))) (. .)))","(ROOT (S (NP (DT The) (JJ only) (NN side) (NN effect)) (VP (VBZ is) (VP (VBN marked) (NP (NP (NN increase)) (PP (IN in) (NP (JJ left) (JJ upperextremity) (NN edema)))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (JJ cardiovascular) (NN section)) (PP (IN for) (NP (JJR more) (NNS details))))) (-RRB- -RRB-)))) (. .)))","(ROOT (S (NP (NNP Solu-Medrol) (NNP IV)) (VP (VBD was) (VP (VBN started) (SBAR (S (NP (NP (CD 2) (NN mg/kg/day)) (, ,) (VP (VBN started) (PP (IN on) (NP (CD 8/5/05)))) (, ,)) (VP (VBD changed) (PP (TO to) (NP (CD 2) (ADJP (JJ mg/kg) (PP (IN by) (NP (NN mouth)))) (JJ oral) (NNS steroids))) (PP (IN on) (NP (CD 6/13/05)))))))) (. .)))","(ROOT (SINV (S (VP (VBG Begantapering) (PP (IN with) (NP (NP (NNS steroids)) (PP (IN at) (NP (NP (CD 100) (NN mg) (NN b.i.d.)) (PP (IN on) (NP (CD 11/18/05))))))))) (, ,) (VP (VBD decreased) (NP (JJ to80) (NN mg)) (PP (PP (IN on) (NP (CD 8/20/05))) (, ,) (CC and) (RB down) (PP (TO to) (NP (CD 60) (NN mg))))) (NP (NP (RB twice) (JJ daily)) (PP (IN on) (NP (CD 10/24/05)))) (. .)))","(ROOT (S (NP (NNP Rapamycin)) (VP (VBD was) (VP (VBN started) (PP (IN on) (NP (NP (CD 10/10/05)) (, ,) (NP (NP (NN goal) (NN level)) (PP (IN between) (NP (CD 3) (CC and) (CD 12)))))))) (. .)))","(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (VP (VBN been) (VP (VBN therapeutic) (PP (IN since) (S (VP (VBG initiating) (NP (NN therapy)))))))) (. .)))","(ROOT (S (NP (NP (NNS Sheremains)) (PP (IN on) (NP (NNP GVH) (NN diet)))) (, ,) (VP (VBG coordinating) (PP (IN with) (NP (NN dietary) (CC and) (NN kitchen) (NN forcorrect) (NN menu)))) (. .)))","(ROOT (S (NP (PRP She)) (ADVP (RB also)) (VP (VBZ has) (VP (VBN been) (PP (IN on) (NP (NP (JJ lactose-restricted) (NN diet) (NNS thathas)) (VP (VBN helped) (NP (NP (DT the) (JJ stool) (NN volume)) (CONJP (RB as) (RB well)) (NP (CD .2)))))))) (. .)))","(ROOT (NP (NP (NNP Hematology)) (: :) (NP (NP (DT The) (NN patient)) (PP (IN with) (NP (NP (DT no) (JJ active) (NN bleeding)) (VP (VBN wastransfused) (PP (IN for) (NP (JJ hematocrit) (ADJP (ADJP (QP (JJR less) (IN than) (CD 26))) (CC and) (ADJP (RB platelets) (JJR less))) (NNS than20))))))) (. .)))","(ROOT (S (NP (PRP She)) (VP (VBD did) (VP (VB have) (NP (NP (JJ intermittent) (JJ bright) (JJ red) (NN blood)) (CC and) (NP (NP (NNS clots)) (NP (NN instool)) (, ,) (ADVP (RBS most) (RB recently)))) (PP (IN on) (NP (CD 10/2/05) (CC and) (CD 8/25/05))))) (. .)))","(ROOT (S (NP (DT This)) (VP (VBD wasattributed) (S (VP (TO to) (VP (VB have) (NP (NP (JJ large) (NNS hemorrhoids)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN found) (ADVP (RB oncolonoscopy))))))))))) (. .)))","(ROOT (S (NP (PRP She)) (VP (VBD remained) (ADJP (RB hemodynamically) (JJ stable)) (PP (IN throughout) (NP (CD .3)))) (. .)))","(ROOT (NP (NP (JJ Infectious) (NN disease)) (: :) (S (NP (DT The) (NN patient)) (VP (VBD remained) (NP (NP (JJ afebrile) (NN throughouther) (NN hospitalization)) (, ,) (VP (VBN maintained) (PP (IN on) (NP (NP (JJ prophylactic) (NN medication) (NN ofMepron)) (CC and) (NP (NN acyclovir)))))))) (. .)))","(ROOT (FRAG (NP (NP (JJ Cytomegalovirus) (JJ viral) (NN load)) (PP (IN on) (NP (CD 2/7/05) (CD ,8)))) (: /) (NP (NP (CD 5/05) (, ,) (CD 5/10/05) (, ,) (CC and) (CD 10/10/05)) (, ,) (ADJP (RB all) (JJ negative))) (. .)))","(ROOT (S (NP (NNP CMV) (JJ viral) (NN loadon) (CD 9/6/05)) (VP (VBD was) (VP (VBG pending) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (DT this) (NN dictation))))))) (. .)))","(ROOT (S (S (NP (NNP Thepatient)) (VP (VBZ is) (S (VP (TO to) (VP (VB remain) (PP (IN on) (NP (NN acyclovir)))))))) (CC and) (S (NP (NNP Mepron)) (ADVP (RB once)) (VP (VBD transferred) (NP (CD .4)))) (. .)))","(ROOT (S (NP (NP (NNP Cardiovascular)) (: :) (NP (NP (DT The) (NN patient)) (VP (VBN remained) (S (ADJP (RB hemodynamically) (JJ stable))))) (, ,)) (VP (VBD did) (RB not) (VP (VB get) (NP (NN hypotensive)) (PP (IN throughout) (NP (DT the) (NN admission) (CD .5))))) (. .)))","(ROOT (NP (NP (NNS Extremities)) (: :) (S (NP (DT The) (NN patient)) (VP (VBD had) (VP (VBN left) (NP (NP (JJ upper) (NN extremity) (NNS swelling)) (, ,) (ADJP (RB markedly) (JJ worsened)) (, ,) (VP (VBG starting) (PP (IN on) (NP (NNS tacrolimus))))) (, ,) (SBAR (IN as) (S (NP (DT this)) (VP (VBZ is) (VP (VBN known) (NP (NP (JJ tocause) (JJ capillary) (NN leak) (NN syndrome)) (ADJP (JJ due) (PP (TO to) (NP (NP (DT an) (NN ultrasound)) (PP (IN of) (NP (DT the) (NN leftupper) (NN extremity)))))) (PP (IN on) (NP (CD 11/28/05))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ negative) (PP (IN for) (NP (NNP DVT))))))))))))))) (. .)))","(ROOT (S (NP (NP (NNS Etiologyis)) (ADJP (JJ likely) (RB due) (PP (TO to) (NP (NN lymphedema) (JJ secondary))) (S (VP (TO to) (VP (VB axillary) (NP (JJ resection) (NN whenthe) (NN patient))))))) (VP (VBD had) (NP (NP (NN breast) (NN cancer) (CC and) (NN capillary) (NN leak)) (VP (VBN syndromeassociated) (PP (IN with) (NP (NNP ONTAK)))))) (. .)))","(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (DT an) (NN echocardiogram)) (SBAR (S (VP (VBZ toassess) (NP (NP (DT the) (NN etiology)) (PP (IN of) (NP (NP (JJ peripheral) (NN edema)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD showed) (NP (NP (DT an) (NN ejectionfraction)) (PP (IN of) (NP (NP (CD 60) (NN %)) (, ,) (NP (JJ mild) (JJ aortic) (NN insufficiency)) (, ,) (CC and) (NP (JJ aortic) (NNS stenosis)) (, ,) (NP (JJ borderline) (JJ diastolic) (NN dysfunction)) (, ,) (NP (JJ normal) (NN right) (NN heart)) (, ,) (CC and) (NP (JJ minimalpericardial) (NN effusion) (CD .6)))))))))))))))) (. .)))","(ROOT (S (ADVP (RB Pulmonary)) (: :) (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (CD one) (NN episode)) (PP (IN of) (NP (NN dyspnea) (NN whenspeaking)))) (PP (IN on) (NP (NP (CD 11/16/05)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBN resolved) (PP (IN without) (NP (NP (JJ further) (NN symptomsthroughout)) (NP (DT the) (NN admission)))))))))) (. .)))","(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (NN chest) (NN x-ray) (NNS on10/6/05)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD showed) (NP (JJ small) (JJ left) (JJ pleural) (NN effusion)) (PP (IN without) (NP (JJ otherabnormalities) (CD .7)))))))) (. .)))","(ROOT (FRAG (NP (NNP Gastrointestinal)) (: :) (S (ADVP (RB Mouth)) (, ,) (S (NP (DT the) (NN patient)) (VP (VBD had) (NP (NP (NP (JJ dry) (NN mouth)) (, ,) (ADJP (JJ likely) (JJ acomponent)) (PP (IN of) (NP (NN graft)))) (CC versus) (NP (NP (NN host) (NN disease)) (VP (VBG using) (NP (NN ice) (NNS chips))))))) (CC and) (S (NP (NN mouthcoat)) (VP (VBZ is) (ADJP (JJ helpful) (PP (TO to) (NP (PRP her))))))) (. .)))","(ROOT (S (NP (PRP She)) (VP (MD should) (VP (VB continue) (NP (DT this)) (PP (IN throughout) (NP (CD .8))))) (. .)))","(ROOT (FRAG (NP (NNP Gut)) (: :) (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (NP (JJ persistent) (JJ loose) (NNS stools)) (VP (VBN improved))) (PRN (-LRB- -LRB-) (NP (JJ seeoncology) (NN section)) (-RRB- -RRB-))))) (. .)))","(ROOT (S (NP (JJ Clostridium) (NN difficile) (NN testing)) (VP (VBD sent) (SBAR (S (NP (CD on8/26/05) (CC and) (CD 3/5/05)) (VP (VBD were) (ADJP (JJ negative)))))) (. .)))","(ROOT (SINV (S (NP (PRP She)) (VP (VBD had) (NP (NP (JJ intermittent) (JJ brightred) (NN blood)) (PP (IN per) (NP (NN rectum))) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN related) (PP (TO to) (NP (JJ external) (NNS hemorrhoids)))))))))) (, ,) (VP (VBD asstated) (ADVP (RB above)) (PP (IN in) (NP (NNP GI)))) (NP (ADJP (JJ section.Colonoscopy) (PP (IN on) (NP (CD 5/10/05)))) (JJ revealed) (NN stage) (NNP II) (NNP GVHD)) (PP (IN on) (NP (NN biopsy))) (PP (IN with) (NP (NP (JJ nogross) (JJ visual) (NN evidence)) (PP (IN of) (NP (NNP bleed))))) (. .)))","(ROOT (S (PP (IN As) (NP (DT the) (NN fact))) (ADVP (RB now)) (, ,) (NP (DT the) (NN patient)) (VP (VBD wasadmitted) (PP (IN on) (NP (CD 7/16/05))) (PP (IN with) (NP (JJ bright) (JJ red) (NN blood)))) (. .)))","(ROOT (S (NP (NP (DT The) (JJ colonoscopy) (NN wasnotable)) (PP (IN for) (NP (NP (JJ large) (JJ hemorrhagic) (NN mucosa)) (, ,) (NP (JJ intubating) (NNS internalhemorrhoids)) (, ,) (CC and) (ADVP (IN at) (NP (DT that) (NN time))) (NP (NNS biopsies))))) (VP (VBD were) (ADJP (JJ negative) (PP (IN for) (NP (JJ graftversus) (NN host) (NN disease))))) (. .)))","(ROOT (S (NP (DT This)) (VP (VBD was) (PP (IN on) (NP (CD 3/5/05)))) (. .)))","(ROOT (S (NP (NP (NNP Liver) (NN transaminitison) (CD 8/29/05)) (, ,) (ADJP (RB likely) (JJ due) (PP (TO to) (NP (NNP ONTAK))))) (VP (MD would) (VP (VB be) (VP (VBN followed) (PP (IN as) (NP (NN anoutpatient)))))) (. .)))","(ROOT (S (NP (DT The) (NN patient)) (ADVP (RB also)) (VP (VP (VBD had) (NP (JJ transient) (NNP LFT) (NN abnormalitieswhen)) (VP (ADVP (RB first)) (VBN admitted))) (CC and) (VP (VBZ has) (ADVP (IN since)) (VP (VBN resolved) (PP (IN since) (NP (NN discontinuingBactrim)))))) (. .)))","(ROOT (S (NP (DT The) (NN bilirubin)) (VP (VBD remained) (ADJP (JJ normal))) (. .)))","(ROOT (NP (NP (DT The) (NN patient)) (QP (CD wasasymptomatic) (CD .9)) (. .)))","(ROOT (S (ADVP (RB Rectum)) (: :) (NP (DT The) (NN patient)) (VP (VBD had) (NP (NNP Anusol)) (SBAR (IN as) (S (S (VP (VBN needed) (PP (IN for) (NP (NN hemorrhoids.She))))) (VP (VBD was) (ADVP (RB not) (NP (DT a) (NN candidate)) (PP (IN for) (NP (NP (JJ surgical) (NN intervention)) (PP (IN due) (NP (NN toimmunosuppression) (CC and) (NN infection) (NN risk)))))) (NP (CD .10)))))) (. .)))","(ROOT (NP (NP (NNP Renal)) (: :) (NP (NP (DT The) (NN patient)) (VP (VBN repeated) (S (VP (VBG increasing) (NP (NN creatinine)) (PP (TO to) (NP (CD 1.3))))))) (. .)))","(ROOT (S (NP (PRP She)) (VP (VBD maintained) (NP (NP (DT a) (NN level)) (PP (IN of) (NP (QP (CD 0.9) (TO to) (CD 1.2))))) (PP (IN throughout) (NP (DT the) (JJ last) (NNS fewweeks))) (PP (IN before) (NP (NN discharge) (CD .11)))) (. .)))","(ROOT (FRAG (NP (NP (NNS Fluids)) (, ,) (NP (NNS electrolytes)) (, ,) (CC and) (NP (NN nutrition))) (: :) (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ markedperipheral) (NN edema)))) (. .)))","(ROOT (S (NP (NNS Diureses)) (VP (VBD worked) (ADVP (RB well))) (. .)))","(ROOT (S (S (NP (DT The) (NN patient)) (VP (VBD was) (ADVP (RB up) (NP (CD to18) (NN kg))) (PP (IN above) (NP (JJ admit) (NN weight))))) (CC and) (S (ADVP (RB now)) (NP (PRP she)) (VP (VBZ is) (ADVP (NP (QP (RB only) (CD 3)) (NN kg)) (RB up)) (PP (IN from) (NP (NP (JJ theadmit) (NN weight)) (PP (IN on) (NP (CD 10/24/05))))))) (. .)))","(ROOT (S (NP (PRP She)) (VP (VBZ is) (PP (IN on) (NP (NNP Lasix) (CD 40))) (S (VP (VB mg) (NP (RB twice) (JJ daily) (NN bymouth))))) (. .)))","(ROOT (S (NP (DT This)) (VP (VBZ is) (ADJP (RB likely) (JJ secondary) (PP (TO to) (NP (NN combination)))) (PP (TO to) (NP (NP (NN venousinsufficiency)) (, ,) (NP (NNS steroids)) (, ,) (CC and) (NP (JJ low) (NN albumin))))) (. .)))","(ROOT (S (PP (IN In) (NP (DT the) (NN setting) (NN ofONTAK))) (, ,) (NP (PRP she)) (VP (VBD was) (VP (VBN given) (NP (NN albumin) (CC and) (NN Lasix)) (SBAR (S (NP-TMP (CD three) (NNS times) (RB daily)) (, ,) (NP (NNS whichis)) (ADVP (RB no) (RB longer)) (VP (VBD needed) (ADVP (RB now)) (SBAR (IN that) (S (NP (NP (PRP she)) (SBAR (WHNP (WDT that)) (S (VP (MD would) (RB not) (VP (VB be) (VP (VBG pursuing) (NP (NNP ONTAKtherapy)) (PP (IN until) (NP (NP (DT an) (NN outpatient)) (VP (VBG attending)))))))))) (VP (VBZ decides))))))) (, ,) (ADVP (RB otherwise)))) (. .)))","(ROOT (S (NP (NNP Sheshould)) (VP (VBP have) (NP (NP (DT a) (NN goal) (NN I/O)) (SBAR (WHNP (ADJP (JJ negative) (PP (TO to) (NP (QP (CD 1) (TO to) (CD 1.5))))) (NNS liters)) (S (NP (DT a) (NN day.Monitor)) (VP (VBZ hemodynamics) (ADVP (RB closely)) (SBAR (IN if) (S (NP (DT the) (NN patient)) (VP (VBZ has) (VP (VBN been) (VP (VBN noted) (S (VP (TO to) (VP (VB bedehydrated)))))))))))))) (. .)))","(ROOT (S (S (VP (VBN Encouraged) (UCP (ADJP (JJ ambulation)) (CC and) (PP (IN for) (S (VP (VBG elevation) (S (NP (PRP we)) (VP (VBG wereusing) (NP (NNP Ace) (NN bandage)) (PP (IN like)))))))))) (VP (VBZ wraps)) (. .)))","(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (VP (VBN electrolytesmonitored) (CC and) (VBN repleaded) (PP (IN as) (ADJP (JJ needed))))) (. .)))","(ROOT (S (NP (NNP Nutrition)) (VP (VBD was) (VP (VBG following) (NP (CD .12)))) (. .)))","(ROOT (FRAG (NP (NNP Endocrine)) (: :) (S (NP (NP (DT The) (NN patient) (POS \u0027s)) (NN fingerstick) (NN blood) (NNS sugars)) (VP (VBD were) (NP (NP (JJ 134and) (NNS 163)) (, ,) (VP (VBN improved) (PP (IN since) (NP (NP (JJ steroids) (NN taper)) (VP (VBN initiated)))))))) (. .)))","(ROOT (S (S (NP (PRP She)) (VP (VBP remainedon) (NP (NP (DT the) (JJ sliding) (NN scale)) (ADJP (RB as) (VBN needed))))) (, ,) (ADVP (RB likely)) (S (NP (DT this)) (VP (VBZ is) (ADJP (JJ due) (S (VP (TO to) (VP (VB steroids) (NP (CD .13)))))))) (. .)))","(ROOT (NP (NP (NNP Dermatology)) (: :) (NP (NP (DT The) (ADJP (JJ patient) (PP (IN upon) (NP (NP (NN admission)) (VP (VBN had) (NP (NP (NN significantinvolvement)) (PP (IN of) (NP (NN skin))))) (ADJP (JJ due) (S (VP (TO to) (VP (VB GVH) (NP (QP (JJR greater) (IN than) (CD 80)) (NN %))))))))) (NN body) (NN surface)) (VP (VBN areainvolved))) (. .)))","(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN improved) (ADVP (RB significantly)) (, ,) (SBAR (IN as) (S (NP (DT the) (NN exam)) (VP (VBZ revealedless) (NP (NP (NN erythema)) (, ,) (NP (VBG darkening) (NN rash)) (, ,) (CC and) (NP (VBN decreased) (NN distribution)))))))) (. .)))","(ROOT (S (NP (NNP Thepatient)) (VP (VBZ is) (PP (IN on) (NP (NNP GVH) (NN medication))) (, ,) (SBAR (IN as) (S (VP (VBN stated) (PP (IN in) (NP (NNP Oncology) (NN section))))))) (. .)))","(ROOT (S (NP (NNP Shealso)) (VP (VP (VBD came) (PRT (RP in)) (PP (IN with) (NP (JJ macerated) (NNS areas))) (PP (IN under) (NP (DT both) (NN breast)))) (CC and) (VP (VP (VBD wastreated) (PP (IN with) (NP (JJ miconazole) (NN powder)))) (CC and) (VP (VBD had) (VP (VBN improved) (PP (IN by) (NP (DT the) (NN day) (NN ofdischarge))))) (NP (CD .14)))) (. .)))","(ROOT (NP (NP (NNS Access)) (: :) (S (NP (DT The) (NN patient)) (VP (VBD had) (RB double) (VP (VBN lumen) (NP (NP (NNP Hickman) (NNP catheter)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (NNS erythematous)) (VP (VBG surrounding) (NP (NN exit) (NN site))))))))))) (. .)))","(X (X The) (X cuff) (X has) (X beenexposed) (X for) (X months) (X ,) (X although) (X the) (X patient) (X has) (X had) (X no) (X fevers) (X ,) (X nottender) (X ,) (X outpatient) (X attending) (X requested) (X to) (X keep) (X it) (X lying) (X in.SOCIAL) (X DISPOSITION) (X :) (X The) (X patient) (X accepted) (X at) (X Dwan) (X Uoswe) (X Chehamp) (X Hospital) (X Center) (X We) (X had) (X familymeeting) (X on) (X 8/20/05) (X with) (X all) (X siblings) (X and) (X patient) (X \u0027s) (X son) (X agreed) (X ononce) (X the) (X patient) (X is) (X at) (X home) (X ,) (X need) (X for) (X increased) (X support) (X ,) (X medication) (X compliance) (X ,) (X Mitchel) (X Hursey) (X ,) (X social) (X worker) (X from) (X Tinmasca) (X Hospital) (X is) (X following) (X Dr.) (X KringasDISCHARGE) (X CONDITION) (X :) (X Stable.DISCHARGE) (X MEDICATIONS) (X :) (X Include) (X acyclovir) (X ,) (X Anusol) (X ,) (X Bactroban) (X ,) (X prednisone) (X 60) (X mg) (X by) (X mouthtwice) (X daily) (X ,) (X Mepron) (X 750) (X mg) (X twice) (X daily) (X ,) (X Celexa) (X ,) (X sirolimus) (X 4) (X mg) (X bymouth) (X once) (X daily) (X ,) (X Caltrate) (X ,) (X vitamin) (X D) (X ,) (X and) (X Nexium) (X ,) (X tacrolimus) (X 1) (X %) (X lotion) (X twice) (X daily) (X to) (X affected) (X skin) (X GVHD) (X areas) (X ,) (X and) (X Lasix) (X 40) (X mgby) (X mouth) (X twice) (X daily.eScription) (X document) (X :) (X 2-7972916) (X EMSDictated) (X By) (X :) (X ALTO) (X ,) (X GARLANDAttending) (X :) (X NEVERSON) (X ,) (X JAMAL) (X MARIONDictation) (X ID) (X 5901421D) (X :) (X 8/29/05T) (X :) (X 8/29/05))"]}
